Matt Leath

Matt Leath is an experienced professional who has worked in the pharmaceutical industry for several years. With a background in business administration, Matt has held various positions in companies such as Liquidia Corporation, Akcea Therapeutics, United Therapeutics Corporation, Actelion, and sanofi-aventis. Their roles have involved promoting and educating healthcare professionals about unique therapies for rare diseases such as Hereditary Amyloidosis, pulmonary arterial hypertension, and mycosis fungoides-type cutaneous T-cell lymphoma. Matt's experience showcases their expertise in disease awareness initiatives and product promotion within specialized medical fields.